Thyreopathy in primary care

Czech version

Authors: P. Vlček
Authors‘ workplace: Klinika nukleární medicíny a endokrinologie 2. lékařské fakulty UK a FN Motol Praha, přednosta doc. MUDr. Petr Vlček, CSc.
Published in: Vnitř Lék 2011; 57(9): 786-790
Category: 65th birthday Mudr. Jany Laciné and and 60th birthday Milana Tržila

Overview

Thyroid gland disorders, as the core of all endocrinopathies, affect 5–7% of the population of the Czech Republic, with women being affected 6–8 times more often than men. Clinically, thyreopathies are divided into hormonal production disorders and morphology disorders. Thyroid hormones fT₃, fT₄ and TSH serum levels determine the diagnosis of a thyroid gland disorder. Primary hypothyreosis is characterized by reduced fT₄ and increased TSH. Low T₃ syndrome is a protective reaction of the organism and is associated with conversion of T₄ into hormonally inactive triiodothyronine (rT₃). Primary hyperthyreosis is characterized by higher fT₄ and low TSH levels. Acute thyreoiditis: Inflammatory signs and normal thyroid function, anti-TPO as well as anti-TG are not elevated. Subacute thyreoiditis is manifested as an inflammation, normal anti-TPO and anti-TG, sometimes also hyperthyreosis. Chronic thyreoiditis, Hashimoto‘s struma is among the most frequent causes of hypothyreosis in the Czech Republic and it is diagnosed through high anti-TPO and anti-TG levels and higher TSH. Thyreoidal adenomas and carcinomas are clinically usually euthyroid. Determination of tumour markers –⁠ thyreoglobulines in papillary and follicular carcinomas and calcitonin in medullar carcinoma that requires genetic assessment (determination of germinal mutations, usually with PCR) –⁠ is essential.

Key words:
thyroid gland –⁠ hypothyreosis –⁠ hyperthyreosis –⁠ thyroxin –⁠ TSH –⁠ fT₄ –⁠ inflammation –⁠ tumours

Sources

1. Límanová Z, Němec J, Zamrazil V. Nemoci štítné žlázy. 1. vyd. Praha: Galén 1995.

2. Stárka L, Zamrazil V et al. Základy klinické endokrinologie. 2. vyd. Praha: Maxdorf 2005.

3. McDermott MT. In the clinic. Hypothyroidism. Ann Intern Med 2009; 151: ITC61.

4. Zamrazil V. Subklinické tyreopatie. Intern Med Pro Prax 2004; 5 : 295–299.

5. Vlček P, Neumann J. Karcinom štítné žlázy, pooperační sledování nemocných. 1. vyd. Praha: Maxdorf 2002.

6. Dvořáková S, Václavíková E, Sýkorová V et al. New multiple somatic mutations in the RET proto-oncogene associated with sporadic medullary thyroid carcinoma. Thyroid 2006; 16 : 311–316.

7. Vlček P. Nádory štítné žlázy. In: Límanová Z. Štítná žláza. Edice: Trendy soudobé endokrinologie 2. Praha: Galén 2006 : 299–314.